Sandoz Group AG/€SDZ
1D1W1MYTD1Y5YMAX
About Sandoz Group AG
Sandoz Group AG operates in the pharmaceutical industry, specializing in the development, manufacturing, and distribution of generic medicines and biosimilars. The company's product portfolio includes a wide range of therapeutic areas, such as antibiotics, oncology, and cardiovascular treatments. Sandoz was founded as part of a broader restructuring that involved the separation from Novartis in 2022, with a focus on enhancing the accessibility of high-quality healthcare solutions. Headquartered in Switzerland, Sandoz has a significant global presence with operations spanning across numerous countries. The company emphasizes cost-effective healthcare, leveraging a substantial manufacturing and research capacity to maintain competitive strengths in the global pharmaceutical market.
- Ticker
- €SDZ
- Sector
- Health
- Primary listing
- XGAT
- Employees
- 20,000
- Headquarters
- Basel, Switzerland
- Website
- www.sandoz.com
Sandoz Group AG Metrics
BasicAdvanced
€34B
61.15
€1.27
0.49
€0.87
1.12%
Price and volume
Market cap
€34B
Beta
0.49
52-week high
€81.08
52-week low
€47.01
Average daily volume
822K
Dividend rate
€0.87
Financial strength
Current ratio
1.054
Quick ratio
0.624
Long term debt to equity
52.794
Total debt to equity
68.915
Dividend payout ratio (TTM)
68.89%
Interest coverage (TTM)
5.02%
Profitability
EBITDA (TTM)
1,360.377
Gross margin (TTM)
47.94%
Net profit margin (TTM)
5.53%
Operating margin (TTM)
9.33%
Effective tax rate (TTM)
23.19%
Revenue per employee (TTM)
€501,280
Management effectiveness
Return on assets (TTM)
3.07%
Return on equity (TTM)
7.25%
Valuation
Price to earnings (TTM)
61.147
Price to revenue (TTM)
3.334
Price to book
3.53
Price to tangible book (TTM)
-40.55
Price to free cash flow (TTM)
40.293
Free cash flow yield (TTM)
2.48%
Free cash flow per share (TTM)
1.926
Dividend yield (TTM)
1.12%
Forward dividend yield
1.12%
Growth
Revenue change (TTM)
10.29%
Earnings per share change (TTM)
180.85%
3-year revenue growth (CAGR)
6.89%
3-year earnings per share growth (CAGR)
0.99%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.